The Eurecat technology centre has over 200 patents for highly innovative industrial, digital, biotech and sustainability technologies and has set up nine spin-offs in partnership with other businesses as one of its core technology transfer activities in areas such as digitalising healthcare, textile production, 3D printing and information and communication technologies.

To publicise these and other projects it is running in conjunction with innovation ecosystem stakeholders, Eurecat was at Patents for Innovation, the largest patent fair in Europe, which took place in Madrid on 18-19 January as part of the Science for Industry event.

“Eurecat’s commitment in this area seeks to ramp up the impact of patents, either by licensing technology or by setting up new tech businesses, to generate value and competitiveness,” says Àngel García, Valorisation director at Eurecat.

The purpose of taking part in the Patents for Innovation fair “is to publicise the technologies owned by Eurecat and showcase success stories which explain how they are being transferred through spin-offs, licences or access rights while also forging contacts with prospective customers for these technologies and investors who might be interested in getting involved in the capital rounds of Eurecat spin-offs and in other initiatives which are under consideration over the short and medium term.”

Reinforce 3D, Dipneo and NasApp, three highly innovative spin-offs

One of Eurecat’s spin-offs in attendance at the fair with its own booth is Reinforce 3D, which is developing a new technology patented by Eurecat to reinforce 3D-printed parts, components and products by carbon fibre injection and curing with a polymeric matrix, a market estimated to reach €31.5 billion globally by 2026.

Likewise, spin-off Dipneo, founded by Eurecat in conjunction with Mobile World Capital Barcelona and its accelerator The Collider, has also displayed at the fair the current state of development of its new medical device for automatic resuscitation in case of cardiac arrest. It is based on a new system patented by Eurecat which allows air to be blown into the patient autonomously, a feature which means it is suitable for non-expert users as well as professionals.

Meanwhile, Eurecat’s NasApp spin-off, which makes it possible to generate odour maps with a view to tackling and foreseeing odour pollution incidents using a collaborative app through public and business participation, has delivered an elevator pitch coinciding with the investor round in which it is currently engaged.

At the fair Eurecat also took part in the Facing Challenges Summit, the “Technology Transfer in Companies’ R&D Projects” discussion panel and the investors’ forum.

Valorisation, a lever for transferring technology to enterprises

“Valorisation is how Eurecat helps to add value to the technology developed by the technology centre through licensing and setting up spin-offs as a result of its ongoing applied research and technological innovation,” notes Àngel García.

To do this Eurecat’s Valorisation area “leads the process of identifying technological assets to make them more accessible to the market through an analysis and maturation process which ends with licensing the technology to a third party or setting up a tech-based company to ensure that the resulting return is fed back into innovation operations,” adds Laura López, Eurecat’s head of Scouting.

All this is made possible because “Eurecat pays special attention to and invests resources in its protection strategy for these technological assets to safeguard the intellectual and industrial property (IP) rights which enable them to be valorised when they are transferred,” comments Cristina Arilla, head of the technology centre’s Industrial Property unit.

In addition to identifying assets and furnishing them with IP protection, Eurecat’s valorisation initiatives also encompass market validation and research, helping with asset packaging, concluding pilot agreements with early adopters and, lastly, transferring them to a third party.